News, Partnering

Vical and Teva Pharmaceutical establish sales and marketing agreement for Allovectin-7(r) in Israel

Posted on 03 August 2009

Teva has agreed to pay Vical upfront and milestone payments in exchange for the rights to an exclusive license for Israel.

2 Responses to “Vical and Teva Pharmaceutical establish sales and marketing agreement for Allovectin-7(r) in Israel”

  1. CHris Camillo says:

    Looking for actual licensing agreements so as to use for case study at DePaul Univesity

  2. Hi Chris, thanks for your comment.

    You can find actual licensing agreements through a number of services on our website – either by Dealdocs (under the ‘Reports’ heading) or via our sister service Current Agreements (which you’ll find under the ‘Services’ heading). Are you looking for particular licensing agreements Chris?


Leave a Reply

*

bannerpng
euro-medtech-2012jpg
bio-convention-2012gif

Latest Tweets